9 Meters Biopharma Inc - ESG Rating & Company Profile powered by AI
This ESG assessment for 9 Meters Biopharma Inc represents the company's reporting of the UN Sustainable Development Goals. The report of 9 Meters Biopharma Inc leverages data from across the internet and also from public filings by 9 Meters Biopharma Inc. Browse to the bottom of the page for potential risks for 9 Meters Biopharma Inc based on sector, geography and marketcap.
9 Meters Biopharma Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.1; made up of an environmental score of 2.7, social score of 1.6 and governance score of 2.0.
2.1
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1551 | Voyager Life PLC | 2.2 | Medium |
| 1551 | Source Natural Foods and Herbal Supplements Ltd | 2.2 | Medium |
| 1571 | 9 Meters Biopharma Inc | 2.1 | Medium |
| 1571 | Cerevel Therapeutics Holdings Inc | 2.1 | Medium |
| 1571 | Charlotte's Web Holdings Inc | 2.1 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does 9 Meters Biopharma Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes 9 Meters Biopharma Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes 9 Meters Biopharma Inc report the average age of the workforce?
Sign up for free to unlockDoes 9 Meters Biopharma Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes 9 Meters Biopharma Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes 9 Meters Biopharma Inc disclose cybersecurity risks?
Sign up for free to unlockDoes 9 Meters Biopharma Inc offer flexible work?
Sign up for free to unlockDoes 9 Meters Biopharma Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes 9 Meters Biopharma Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes 9 Meters Biopharma Inc conduct supply chain audits?
Sign up for free to unlockDoes 9 Meters Biopharma Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes 9 Meters Biopharma Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes 9 Meters Biopharma Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes 9 Meters Biopharma Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes 9 Meters Biopharma Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes 9 Meters Biopharma Inc disclose water use targets?
Sign up for free to unlockDoes 9 Meters Biopharma Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid 9 Meters Biopharma Inc have a product recall in the last two years?
Sign up for free to unlockDoes 9 Meters Biopharma Inc disclose incidents of discrimination?
Sign up for free to unlockDoes 9 Meters Biopharma Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas 9 Meters Biopharma Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes 9 Meters Biopharma Inc disclose parental leave metrics?
Sign up for free to unlockDoes 9 Meters Biopharma Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes 9 Meters Biopharma Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes 9 Meters Biopharma Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes 9 Meters Biopharma Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes 9 Meters Biopharma Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes 9 Meters Biopharma Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs 9 Meters Biopharma Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes 9 Meters Biopharma Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes 9 Meters Biopharma Inc disclose its waste policy?
Sign up for free to unlockDoes 9 Meters Biopharma Inc report according to TCFD requirements?
Sign up for free to unlockDoes 9 Meters Biopharma Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes 9 Meters Biopharma Inc disclose energy use targets?
Sign up for free to unlockDoes 9 Meters Biopharma Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes 9 Meters Biopharma Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for 9 Meters Biopharma Inc
These potential risks are based on the size, segment and geographies of the company.
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as well as in Phase IIa clinical trial for treatment of multi-system inflammatory syndrome; and Vurolenatide, a long-acting injectable glucagon-like-peptide-1 that is in Phase 2 clinical trial to treat short bowel syndrome. It also develops NM-102, a small molecule peptide; NM-003, a proprietary long-acting glucagon-like peptide-2 receptor agonist for prevention of acute graft versus host disease; NM-136, a humanized monoclonal antibody for targeted obesity disorders; and NM-004, a double-cleaved mesalamine with an immunomodulator for rare and/or orphan indications. The company is based in Raleigh, North Carolina.